FEI.org
03 October 2023
Author: FEI
The FEI Tribunal has issued its Final Decision in a human anti-doping case.
A sample taken from the Brazilian athlete Pedro Stefani Marino (FEI ID 10017829) on 5 December 2021 during the CEI3* 160 Punta del Este (URU), returned positive for the Prohibited Substance Carboxy-THC. Carboxy-THC is a metabolite of THC (Cannabis) and is included in the Class “S8 Cannabinoids” of the World Anti-Doping Agency (WADA) Prohibited List 2021. The athlete was notified of the violation of the FEI’s Anti-Doping Rules for Human Athletes (ADRHA) on 2 February 2022.
In its Final Decision, the FEI Tribunal decided to suspend the athlete for a period of two years, starting from the date of the Final Decision (2 October 2023). Additionally, all competitive results of the Athlete obtained at the Event and from the date of the hearing onwards (15 May 2023) were disqualified with all the relevant consequences (forfeiture of any medals, points and prizes, etc.). Any competitive results from the conclusion of the Event up until the date of the hearing remained valid. Finally, the Athlete was imposed a fine of CHF 7,500 and ordered to pay costs of CHF 5,000.
The parties can appeal to the Court of Arbitration for Sport (CAS) within 21 days of receipt of the decision.
The full text of the FEI Tribunal’s Final Decision is available here.
Subscribe to:
Post Comments (Atom)
Myanmar: Long-distance equestrian race to be held in Bagan
GNLM.com December 14 2024 A long-distance equestrian competition will be held on 30 December 2024 at Tuyin Valley, near the base of Tuyin...
-
Inside.fei.org 17 December 2020 The FEI Board took a series of key decisions on allocation, cancellation, and reopening of bids for FEI C...
-
Inside.FEI.org 02 September 2024 Author: Mirjam van Huet A total of 145 athletes and 155 horses are currently preparing for the journe...
-
Inside.FEI.org 29 November 2023 Author: FEI Communications Chilean athletes showcased exceptional performance in the Valparaíso region (...
No comments:
Post a Comment